期刊文献+

复方甘草甜素对博莱霉素致肺纤维化大鼠的实验研究 被引量:1

Experimental Study on Effect of Stronger NEO-Minophagen C in Treating Rats with Bleomycin-induced Pulmonary Fibrosis
下载PDF
导出
摘要 目的:观察复方甘草甜素对博莱霉素致肺纤维化模型大鼠肺组织匀浆中超氧化物歧化酶SOD的活性及丙二醛MDA含量的影响,探讨复方甘草甜素在大鼠肺纤维化中的作用机理。方法:126只清洁级SD雄性大鼠,随机分成正常对照组(A组)、博来霉素模型组(B组)、地塞米松干预组(C组)、复方甘草甜素大、中、小剂量组(D、E、F组),每组各21只,除A组外,其余各组采用博莱霉素复制大鼠肺纤维化模型,造模第2天起,D、E、F组每天分别腹腔内注射复方甘草甜素,C组用地塞米松腹腔内注射,A、B组用生理盐水腹腔内,每组分别于7、14、28天随机处死7只大鼠,采集肺组织,制作匀浆,检测各组肺组织匀浆中SOD的活性及MDA含量的变化。结果:复方甘草甜素能提高肺组织匀浆中的SOD活性,降低MDA的含量。结论:复方甘草甜素对肺纤维化大鼠的作用机制,可能与通过调节其体内自由基水平,减轻自由基对肺组织结构的氧化损伤有关,而且复方甘草甜素大剂量组的作用优于中小剂量组,呈一定的量效关系。 Objective: To observe the influence of Stronger NEO-Minophagen C(SNMC) on the level of SOD and MDA from the lung tissues in rats with bleomycin-induced pulmonary fibrosis.Methods:126 healthy SD rats,were randomly divided into 6 groups(n= 21,each):normal control group(group A),bleomycin model group(group B),Dxm group(group C),SNMC of high group(group D),SNMC of moderate and low dosage(group D,E,F).The rat model was induced by bleomycin and respective medicine was given to each group.Every group was sub-divided into three groups(n=7) which was killed in the 7th,14th and 28th day.Then,to check the level of SOD and MDA from the lung tissues in the rats.Results : SNMC could increase the activity of SOD,and lower the contents of MDA from the lung tissues in the rats.Conclusion: SNMC can decrease harmful free radical and increase beneficial free radical scavenger in lung tissue,lesson the oxidative injury of pulmonary tissues caused by free radical in pulmonary fibrosis rats.That is probably the mechanism of SNMC protecting pulmonary tissues.In the same time,it has dose-effect relationship in the change above.
出处 《中华中医药学刊》 CAS 2008年第12期2628-2630,共3页 Chinese Archives of Traditional Chinese Medicine
基金 浙江省中医管理局资助项目(2006C138)
关键词 肺纤维化 复方甘草甜素 博莱霉素 SOD MDA SNMC pulmonary fibrosis bleomycin SOD MDA
  • 相关文献

参考文献4

二级参考文献19

  • 1李震,叶向荣,贾素菊,余美娟,李安国,李祝,郭平,王世军,顾振东.抗肿瘤中药对实验性肿瘤小鼠红细胞膜流动性的影响[J].山东中医学院学报,1995,19(5):353-354. 被引量:4
  • 2牛纪华,赵正举,牟乃洲,董元霞,姜淑君,朱发永.甘草甜素注射液治疗风湿性疾病的临床研究[J].山东中医杂志,1996,15(8):345-347. 被引量:6
  • 3陈祥银 严仪昭 等.丹参、川芎嗪及糖皮质激素对肺纤维化保护作用的实验观察[J].中华结核和呼吸杂志,1987,10(3):152-152.
  • 4徐向田 邹鲁贤.强力宁临床应用的进展.中国医院药学杂志,1989,(9):358-358.
  • 5苏先狮,陈惠明,王立庄.甘草甜素治疗急性和慢性病毒性肝炎的疗效观察及实验研究[J].中医杂志,1982,(11):33-36.
  • 6[7]Nakashima H, Matsui T, Yoshida Y, et al. A new anti-human immunodeficiency virus substancc glycyrrhizin sulfatc; cndowment of glycyrrhizin reverse transcriptasc inbibitor activity by chemical modification. Jpn J Cancer Res 1987; 78 ( 8 ):767-771.
  • 7Nagler A, Firman N, Feferman R, et al, Reduction in pulmonary fibrosis in vivo by halofugione. Am J Respir Crit Crae Med 1996; 154(4pt): 1082 - 1086.
  • 8Taryka AF, Skornik WA, Gooleski JJ, et al. Potentiation of bleomycin induced lung injury by exposure to 70 % oxygen:Aorphologic assessment. Am Rev Res Dis 1982; 126:1074 -1079.
  • 9Szapiel SV. Elson NA, Fulmer JD, et al. Bleomycin - induced interstitial pulmonaty disease in the nude, athymic mouse.Am Rev Res Dis 1979; 120: 893 - 899.
  • 10泉孝英.间质性肺疾患の概念と分类[J].日本临床,1990,48:474-479.

共引文献105

同被引文献1

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部